Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
McDonald’s has had a tenuous relationship with its franchise operators as of late. A new round of royalty fee hikes isn’t likely to help.
If Hollywood studios want to settle the current dual strike, they may have to get much more open about just how popular their shows are.
Unfortunately for the Lachlan Murdoch there is not much by way of peace in the kingdom, and indications are this may be a short reigns.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
Federal Reserve chair Jerome Powell has met his match in the ongoing fight against inflation: skyrocketing oil costs.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Canada’s Liberal Party won a majority promising to distance the country from the US, a major importer of Canadian crude.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.
The warnings come as the industry adapts to seismic shifts in technology — which means it may just have some new tricks up its sleeve.